Emerging Role of microRNAs in Cerebral Stroke Pathophysiology

Amit Kumar Tripathi,Shashi Kant Tiwari,Priyanka Mishra,Manish Jain

DOI: https://doi.org/10.1007/978-981-13-1453-7_10

2019-01-01

Abstract:Cerebral stroke is a major cause of death and physical disability throughout the world, yet therapeutic options remain limited. The outcomes of stroke injury are critical, causing an extensive burden to both the individual patient and society. Current interventions for stroke injury have been demonstrated to be inadequate, mostly attributable to a lack of understanding of the cellular and molecular changes that occur following an ischemic cerebral stroke. MicroRNAs (miRNAs) are small, endogenous, noncoding RNA molecules that have capacity as post-transcriptional negative regulators of a target mRNA by base-pairing with the 3′- untranslated region (3′-UTR). Novel methodologies are being produced to get miRNA-related therapeutics into the brain over an intact BBB, including chemical modification, use of targeting molecules and methods of disrupting the BBB. However, circulating miRNAs are novel, stable, and potential biomarkers for the early diagnosis of acute stroke in humans. These miRNA profiles also indicate the severity of stroke results related to age and sex in rodents. In this chapter, we focus on the pathophysiological role of miRNAs as novel diagnostic and prognostic biomarkers, in addition to promising therapeutic interventions in cerebral stroke patients.